Dr Rakesh C Verma, MD | |
600 Pleasant Valley Blvd, Altoona, PA 16602-4804 | |
(814) 943-3223 | |
Not Available |
Full Name | Dr Rakesh C Verma |
---|---|
Gender | Male |
Speciality | Allergy/immunology |
Experience | 47 Years |
Location | 600 Pleasant Valley Blvd, Altoona, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417937384 | NPI | - | NPPES |
0014087490002 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | MD042079L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Rakesh C Verma, MD 600 Pleasant Valley Blvd, Altoona, PA 16602-4804 Ph: (814) 943-3223 | Dr Rakesh C Verma, MD 600 Pleasant Valley Blvd, Altoona, PA 16602-4804 Ph: (814) 943-3223 |
News Archive
Fisetin, a naturally occurring compound found in strawberries and other fruits and vegetables, slows the onset of motor problems and delays death in three models of Huntington's disease, according to researchers at the Salk Institute for Biological Studies. The study, published in the online edition of Human Molecular Genetics, sets the stage for further investigations into fisetin's neuroprotective properties in Huntington's and other neurodegenerative conditions.
A strong focus on reward combined with a lack of self-control appears to be linked to the tendency to commit an offence.
Castle Biosciences Inc., a leading developer of prognostic tests for rare cancers, announced today the launch of MyUvealMelanoma.com, a website created to educate newly diagnosed patients, their families and healthcare providers about the most common form of eye cancer. MyUvealMelanoma tells the story of this disease, its treatment and the importance of prognostic testing, through the experience of patients who recently faced this devastating diagnosis first-hand.
At the halfway mark, industry giant Anthem Blue Cross is holding on to a slim lead among health insurance providers with a 31% share of California's exchange market. The Covered California exchange released enrollment figures Tuesday for its 11 health plans from Oct. 1 to the end of December.
Advanced Biological Laboratories (ABL) is pleased to announce its recent signature of a non-exclusive international distribution agreement (excluding United States, Australia, Canada and United Kingdom) of virco®TYPE HIV-1, Belgium-based Virco BVBA's HIV resistance interpretation system.
› Verified 4 days ago